申请人:LILLY CO ELI
公开号:WO2014143601A1
公开(公告)日:2014-09-18
The present invention provides isoindolinone compounds, or a pharmaceutically acceptable salt thereof, that inhibit CDC7 and, therefore may be useful in treating cancer.
本发明提供了一种抑制CDC7的异吲哚啉酮化合物,或其药用可接受的盐,因此可能在治疗癌症方面有用。